Shahin Gharakhanian MD Consulting LLC are the proud Corporate Sponsors of the 11th Annual IMVACS: Immunization & Vaccine Summit, Boston 7-9 December, 2016
October 11, 2016
Blog
BIOTECH FINANCES publishes a special issue citing Shahin Gharakhanian MD Consulting LLC
April 28, 2016
BIOTECH FINANCES, a leading professional publication for biotechnology executive and investors has published [online, and in paper, Lyon-Montreal] a special issue [no. 179, 11 April 2016], on the “francophone” biotech community in Boston MA has highlighted the role and cited Shahin Gharakhanian MD Consulting LLC.
Shahin Gharakhanian MD leads Program Committee for 3rd New England Life Sciences Panorama meeting at the Genzyme Center, Cambridge MA, USA ● Meeting Report
April 28, 2016
2016 NE Life Sciences Panorama Meeting 15 March SUMMARY
Shahin Gharakhanian MD leads Program Committee for 3rd New England Life Sciences Panorama meeting to be held 15 March 2016 at the Genzyme Center, Cambridge MA, USA
March 14, 2016
02.18.2016 FINAL PROGRAM Annual LS Panorama
Presentation at the International Conference on Vaccine R&D, Baltimore MD, 04 November, 2015
November 27, 2015
Methodological challenges in the Clinical Development of HIV Therapeutic Vaccines. Infection with Human Immunodeficiency Virus (HIV) is a chronic clinical state where discrete, viral replication and homeostatic proliferation of infected memory T cells maintain HIV reservoirs. The medical management of HIV is regarded as a major R&D achievement and...
Presentation of phase I and phase II clinical trial results at the IAS: International AIDS Society Conference & IAS HIV Cure Symposium
August 9, 2015
18-20 July 2015, Vancouver, Canada.
Dr Shahin Gharakhanian Interview
June 3, 2015
http://www.hiv-reservoir.net/
Shahin Gharakhanian MD, Leads the Program Committee of the 2015 Life Sciences Annual Panorama Meeting at the Genzyme Center, Cambridge MA, USA, 18 March 2015. Program Included.
March 16, 2015
FACCNE LIFE SCIENCES EVENT Cambridge 18MAR2015
We are pleased to announce a new collaboration agreement concluded between Shahin Gharakhanian MD Consulting LLC (Cambridge MA) and BIONOR PHARMA (Oslo, Norway).
November 10, 2014
BIONOR PHARMA is a leading vaccine company searching for breakthrough treatments for HIV and other lethal viruses [ www.bionorpharma.com ].
Presented at the 4th Conference on Vaccines & Vaccination, Valencia, Spain, 25 September 2015
September 23, 2014
VAC-3S vaccine, a novel approach to the therapeutic management of HIV Infection. Overview of phase I and phase II clinical vaccine development programs. R Ho Tsong Fang, O Launay, C Katlama, J Crouzet, B Autran, V Vieillard, P Debré, S Gharakhanian 2014.09 VAC-3S J Vaccines Vaccin 2014.55